113: Negative Xanax Trials, PSSD in the New York Times, SNOMED creates a code for withdrawal

A roundup of notable news in the world psychiatric drugs and withdrawal.

Publication Bias in Original Xanax Trials

A new study on publication bias of the benzodiazepine Xanax has been released. According to researchers from Harvard, Massachusetts General Hospital, McLean Hospital, and former FDA reviewer Eric Turner, four of the five original studies on the effectiveness of alprazolam (Xanax) found it to be no better than a p…